These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effect of neurokinin A, substance P and calcitonin gene related peptide in peripheral hyperalgesia in the rat paw. Nakamura-Craig M, Gill BK. Neurosci Lett; 1991 Mar 11; 124(1):49-51. PubMed ID: 1713317 [Abstract] [Full Text] [Related]
4. Nociceptive effects induced by intrathecal administration of prostaglandin D2, E2, or F2 alpha to conscious mice. Uda R, Horiguchi S, Ito S, Hyodo M, Hayaishi O. Brain Res; 1990 Feb 26; 510(1):26-32. PubMed ID: 2322844 [Abstract] [Full Text] [Related]
5. Mediation of primary afferent peripheral hyperalgesia by the cAMP second messenger system. Taiwo YO, Bjerknes LK, Goetzl EJ, Levine JD. Neuroscience; 1989 Feb 26; 32(3):577-80. PubMed ID: 2557557 [Abstract] [Full Text] [Related]
9. Prostaglandin effects after elimination of indirect hyperalgesic mechanisms in the skin of the rat. Taiwo YO, Levine JD. Brain Res; 1989 Jul 17; 492(1-2):397-9. PubMed ID: 2665905 [Abstract] [Full Text] [Related]
10. Pharmacological evidence for a role of lipoxygenase products in platelet-activating factor (PAF)-induced hyperalgesia. Dallob A, Guindon Y, Goldenberg MM. Biochem Pharmacol; 1987 Oct 01; 36(19):3201-4. PubMed ID: 2822047 [Abstract] [Full Text] [Related]
13. Captopril does not potentiate hypotension and algesia by substance P. Hui SC, Ogle CW. Clin Exp Pharmacol Physiol; 1986 Oct 01; 13(11-12):819-22. PubMed ID: 2435436 [Abstract] [Full Text] [Related]
15. Intrathecal substance P-induced thermal hyperalgesia and spinal release of prostaglandin E2 and amino acids. Hua XY, Chen P, Marsala M, Yaksh TL. Neuroscience; 1999 Mar 01; 89(2):525-34. PubMed ID: 10077333 [Abstract] [Full Text] [Related]
16. Effects of the bisphosphonate ibandronate on hyperalgesia, substance P, and cytokine levels in a rat model of persistent inflammatory pain. Bianchi M, Franchi S, Ferrario P, Sotgiu ML, Sacerdote P. Eur J Pain; 2008 Apr 01; 12(3):284-92. PubMed ID: 17664076 [Abstract] [Full Text] [Related]
17. Involvement of spinal substance P and excitatory amino acids in inflammatory hyperalgesia in rats. Okano K, Kuraishi Y, Satoh M. Jpn J Pharmacol; 1998 Jan 01; 76(1):15-22. PubMed ID: 9517400 [Abstract] [Full Text] [Related]
18. Nociceptive effect of subcutaneously injected interleukin-12 is mediated by endothelin (ET) acting on ETB receptors in rats. Verri WA, Molina RO, Schivo IR, Cunha TM, Parada CA, Poole S, Ferreira SH, Cunha FQ. J Pharmacol Exp Ther; 2005 Nov 01; 315(2):609-15. PubMed ID: 16024732 [Abstract] [Full Text] [Related]
19. Contribution of interleukin-1 beta to the inflammation-induced increase in nerve growth factor levels and inflammatory hyperalgesia. Safieh-Garabedian B, Poole S, Allchorne A, Winter J, Woolf CJ. Br J Pharmacol; 1995 Aug 01; 115(7):1265-75. PubMed ID: 7582555 [Abstract] [Full Text] [Related]
20. Nitric oxide mediates long-term hyperalgesic and antinociceptive effects of the N-terminus of substance P in the formalin assay in mice. Goettl VM, Larson AA. Pain; 1996 Oct 01; 67(2-3):435-41. PubMed ID: 8951939 [Abstract] [Full Text] [Related] Page: [Next] [New Search]